Kevin E. Weddington

Array ( [id] => 5304144 [patent_doc_number] => 20090298796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'REDUCING RISK OF TYPE 2 DIABETES (T2D)' [patent_app_type] => utility [patent_app_number] => 12/298627 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5789 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298796.pdf [firstpage_image] =>[orig_patent_app_number] => 12298627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225596 [patent_doc_number] => 20070254863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Use of CBx cannabinoid receptor modulators as potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 11/796740 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15574 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254863.pdf [firstpage_image] =>[orig_patent_app_number] => 11796740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225595 [patent_doc_number] => 20070254862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 11/796716 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24922 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254862.pdf [firstpage_image] =>[orig_patent_app_number] => 11796716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705177 [patent_doc_number] => 20080064701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Anti-diabetic combinations' [patent_app_type] => utility [patent_app_number] => 11/789080 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9702 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064701.pdf [firstpage_image] =>[orig_patent_app_number] => 11789080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210935 [patent_doc_number] => 20070249519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'METHODS FOR THE UPREGULATION OF GLUT4 VIA MODULATION OF PPAR DELTA IN ADIPOSE TISSUE AND FOR THE TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 11/737145 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16978 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249519.pdf [firstpage_image] =>[orig_patent_app_number] => 11737145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304196 [patent_doc_number] => 20090298848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Methods and Compositions for Treating Barth Syndrome, Cardiomyopathy, Mitochondrial Diseases and Other Conditions' [patent_app_type] => utility [patent_app_number] => 12/297356 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8945 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298848.pdf [firstpage_image] =>[orig_patent_app_number] => 12297356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4803662 [patent_doc_number] => 20080015251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Means and method for treating lipotoxicity and other metabolically related phenomena' [patent_app_type] => utility [patent_app_number] => 11/783609 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14043 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015251.pdf [firstpage_image] =>[orig_patent_app_number] => 11783609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4580147 [patent_doc_number] => 07834050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Small molecule insulin mimetics absent quinones' [patent_app_type] => utility [patent_app_number] => 11/692552 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7860 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834050.pdf [firstpage_image] =>[orig_patent_app_number] => 11692552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795916 [patent_doc_number] => 08124622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Triglyceride-lowering agent and hyperinsulinism-ameliorating agent' [patent_app_type] => utility [patent_app_number] => 12/293433 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3600 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124622.pdf [firstpage_image] =>[orig_patent_app_number] => 12293433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068978 [patent_doc_number] => 20070190079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'METHODS FOR THE SELECTIVE MODULATION OF PPAR' [patent_app_type] => utility [patent_app_number] => 11/687949 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13630 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190079.pdf [firstpage_image] =>[orig_patent_app_number] => 11687949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599910 [patent_doc_number] => 20100292277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'COMBINATION TREATMENT OF METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/294530 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9276 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292277.pdf [firstpage_image] =>[orig_patent_app_number] => 12294530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498680 [patent_doc_number] => 20100286184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'AQUEOUS SOLUTION OF CONOPHYLLINE AND/OR CONOPHYLLIDINE' [patent_app_type] => utility [patent_app_number] => 12/281940 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9855 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286184.pdf [firstpage_image] =>[orig_patent_app_number] => 12281940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8102995 [patent_doc_number] => 08153144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Stable multiphase composition comprising alkylamphoacetate' [patent_app_type] => utility [patent_app_number] => 11/710181 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10571 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153144.pdf [firstpage_image] =>[orig_patent_app_number] => 11710181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6597112 [patent_doc_number] => 20100048641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating Diseases' [patent_app_type] => utility [patent_app_number] => 12/224417 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18473 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048641.pdf [firstpage_image] =>[orig_patent_app_number] => 12224417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070357 [patent_doc_number] => 20070191459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels' [patent_app_type] => utility [patent_app_number] => 11/673709 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14274 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191459.pdf [firstpage_image] =>[orig_patent_app_number] => 11673709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83886 [patent_doc_number] => 07741367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Method of using abscisic acid to treat diseases and disorders' [patent_app_type] => utility [patent_app_number] => 11/672223 [patent_app_country] => US [patent_app_date] => 2007-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 15 [patent_no_of_words] => 25829 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741367.pdf [firstpage_image] =>[orig_patent_app_number] => 11672223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005672 [patent_doc_number] => 20070203244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'INHIBITORS OF MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE FOR THE TREATMENT OF INSULIN-DEPENDENT DIABETES MELLITUS' [patent_app_type] => utility [patent_app_number] => 11/672405 [patent_app_country] => US [patent_app_date] => 2007-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20359 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203244.pdf [firstpage_image] =>[orig_patent_app_number] => 11672405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323651 [patent_doc_number] => 08658672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'HIF-1α activating agent' [patent_app_type] => utility [patent_app_number] => 12/094748 [patent_app_country] => US [patent_app_date] => 2007-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9572 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12094748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338048 [patent_doc_number] => 20090054512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'USE OF ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/158772 [patent_app_country] => US [patent_app_date] => 2007-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9891 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054512.pdf [firstpage_image] =>[orig_patent_app_number] => 12158772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6515770 [patent_doc_number] => 20100216800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Treatment of Type 2 Diabetes With a Combination of DPIV Inhibitor and Metformin or Thiazolidinedione' [patent_app_type] => utility [patent_app_number] => 12/086942 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4290 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216800.pdf [firstpage_image] =>[orig_patent_app_number] => 12086942 [rel_patent_id] =>[rel_patent_doc_number] =>)